Associate Professor, Department of Population Health
Associate Professor, Department of Medicine
As a clinician investigator at NYU School of Medicine, in the Dept. of Population Health and Dept. of Medicine, my research focuses on the implications of substance use for individuals and health systems, and on improving the identification and treatment of addiction in general medical settings. In 2010 I received a NIDA K23 career development award to study patient self-administered substance use screening in primary care settings. Following on that award, I received a NIDA R34 to develop and test a technology-assisted approach to integrating screening and brief intervention into medical visits. I was Co-Lead Investigator of a multi-site NIDA Clinical Trials Network (CTN) study (CTN 0059) that developed and validated a brief substance use screening instrument (TAPS Tool). Currently, I am Lead Investigator of a NIDA CTN study (CTN 0062-Ot) that seeks to integrate the NIDA Common Data Elements into electronic health records in large health systems. My prior work has included the use of large public health data sets to estimate the population prevalence of opioid use disorder, policy research on models of opioid maintenance treatment and clinical research on an HIV prevention intervention in a methadone maintenance treatment program. My research is informed by my clinical practice as a primary care and addiction medicine physician at Bellevue Hospital (part of the NYC Health and Hospitals system).
Positions and Honors
Other Experience and Professional Memberships
2007 American Board of Internal Medicine
2009-Pres Substance Abuse Interest Group, Society of General Internal Medicine
2010-Pres Association for Medical Education and Research in Substance Abuse
2011 Treatment Decision Guide Special Interest Group, NIDA Clinical Trials Network
2012-2015 Scientific Review Committee, NYU-HHC CTSI
2012 American Board of Addiction Medicine
2015-2016 Abstract Committee Co-Chair, Association for Medical Education and Research in SubstanceAbuse (AMERSA), 2015 and 2016 annual meetings
2016-2017 Chair of the Executive Committee, 14th Annual conference of the International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA)
2016-Pres Member of the Coordinating Committee, International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA)
Honors and Awards
1994 Phi Beta Kappa, Columbia University, New York
1999 Golding Distinguished Scholar Fellowship, Albert Einstein College of Medicine, New York
2003 Alpha Omega Alpha, Albert Einstein College of Medicine, New York
2009 National Institutes of Health Loan Repayment Program
2010 Michael Saperstein Medical Scholar, NYU Dept. of Medicine
2013 Best Abstract award, Association for Medical Education and Research in Substance Abuse
2014 Best Peer Review award, Substance Abuse
2011-2015 National Institutes of Health Loan Repayment Program
Contribution to Science
2.Integrating substance use disorder treatment into medical care. My work on screening tools stems from a larger interest in integrating addiction treatment with medical care. While only a small proportion of individuals with substance use disorders are seen in the specialty addiction treatment setting, they do have frequent contacts with the health care system. Health care contacts present an opportunity to provide substance use interventions that can improve population health. As a pre-medical student, I explored the potential to expand access to opioid maintenance treatment through office-based pharmacotherapy, and later saw this become a reality with the approval of buprenorphine and the Drug Addiction Treatment Act of 2000. During my fellowship in Medicine and Public Health Research, I collaborated with the New York City Department of Health and Mental Hygiene (DOHMH) on two projects: one to author a practice guideline for primary care practitioners on improving care for patients with substance use, and a second to describe the health burden of illicit opioid use in New York City using large administrative data sets. I participated in a NIDA working group, led by former Deputy Director of the Office of National Drug Control Policy A. Thomas McLellan, on addressing addictions using the chronic care model. I am currently Lead Investigator of a new study in the NIDA Clinical Trials Network (CTN-0062) that is working with two large health care systems to incorporate substance use information into electronic health records.
3.Substance use screening in dental clinics. My interest in utilizing routine health care contacts to improve the health of substance-using populations also led me to explore the potential for incorporating substance use screening into novel settings. One branch of this work has been to explore screening for tobacco, alcohol, and drug use in dental clinics. Dental providers see a broad proportion of the population, and have regular contact with individuals who may not otherwise visit medical providers. In collaboration with Donna Shelley, MD, MPH, (Co-Investigator on the proposed study), I conducted a survey of dentists in a practice-based research network, and participated in developing a large national survey to describe dentists’ practices and attitudes regarding addressing substance use as part of routine dental care.
4.Addressing new health challenges in substance use disorder treatment programs. I have also conducted research within addiction treatment programs on interventions to improve the health of their patient populations. During medical school, I designed, implemented, and tested an intervention to improve access to sterile injecting equipment for patients in a methadone treatment program. This study was an early formative experience because it introduced me to the challenges and rewards of implementing interventions that are integrated into existing health systems, and thus have potential to be sustained and disseminated. Currently, I am working with a geriatrician to characterize the aging methadone maintenance treatment population, and develop interventions to address their needs.
5. Medication for addiction treatment in medical settings. As a researcher focused on improving population health, I am keenly aware of how under-utilized addiction medications are in medical settings. With Dr. Joshua Lee and other colleagues in the Division on Tobacco, Alcohol, and Drug Use, I have been deeply involved in clinical practice, education, and research that aims to improve and sustain addictions treatment in general health care settings. As a result of this experience, I was invited to join the NIDA Clinical Decision Support for Opioid Use Disorders Expert Panel and the study that grew out of it (CTN-0076- Ot), which is developing an electronic health record-integrated decision support tool to support primary care providers in treating patients with opioid use disorders. I am a current member of the NYC Department of Health and Mental Hygiene Buprenorphine Advisory Panel, which guides policy and educates clinicians to increase the delivery of buprenorphine treatment in NYC.
Ongoing Research Support1R34 DA040830-01 - McNeely (PI) - 07/01/2016-06/31/2019 NIH/NIDA Leveraging technology to address unhealthy drug use in primary care settings. The proposed study aims to develop and test a new model of integrating substance use screening and brief interventions in primary care settings. The Substance Use Screening and Intervention Tool (SUSIT) utilizes health information technology to assist primary care providers in addressing unhealthy drug use by providing patient self-administered screening, clinical decision support, and clinical reminders. 5UG1DA013035-14S4 - Nunes and Rotrosen (PI) NIH/NIDA NIDA Clinical Trials Network: Greater New York Node – Supplement CTN-0062-Ot - 09/01/2015-05/31/2020 A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) into the Electronic Health Record (EHR) in Large Primary Care Settings This 4-phase implementation study seeks to incorporate the NIDA CDEs into the EHR in primary care settings. It aims to develop and implement a strategy for screening, with results entered into the EHR and paired with clinical decision support at the point of care, along with an EHR-integrated system for treatment referrals. Role: Lead Investigator CTN-0062-Ot-A1 - 06/01/2017-05/31/2020 Implementing the Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS) Tool in rural federally-qualified health centers: An ancillary study of the CDE-EHR-PC Study. This ancillary study to NIDA CTN-0062-Ot will study the implementation of electronic health record (EHR) integrated screening for substance use in a network of rural federally qualified health centers. Role: Lead Investigator R13AA025541 - McNeely and Shelley (mPI) - 04/10/2017-03/31/2018 NIH/NIAAA and NIDA Screening and brief intervention at the intersection of research, policy and practice: Advancing knowledge and meeting new challenges This conference grant proposal is to support an alcohol and drug screening and brief intervention research conference in New York, NY, September 14-15, 2017. The conference will be the 14th annual meeting of the International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA). 5R25DA022461-09 Gourevitch (PI) 06/01/2017-05/31/2022 NIH/NIDA Substance Abuse Research Education and Training (SARET) The primary goal of this initiative is to design, implement and evaluate a substance abuse research training program for physicians, nurses and dentists that will stimulate participants’ interest in pursuing careers in drug abuse research. Role: Co-Investigator Completed Research Support K23 DA030395 - McNeely (PI) - 09/30/2010-02/29/2016 NIH/NIDA Screening for substance use with computer assisted self interview in primary care The goal of this study is to determine the validity and feasibility of a patient self-administered substance use screening and assessment in primary care. CTN-0059 - Schwartz (PI) - 01/01/2014-08/31/2015 NIH/NIDA CTN The TAPS Tool: Screen and Brief Assessment Tool Validation Study This study of the NIDA Clinical Trials Network developed and validated a 4-item screen and a two-stage screening and brief assessment tool to screen and assess primary care patients for tobacco, alcohol, prescription drug, and illicit substance use and problems related to their use. Role: Co-Lead Investigator and Site PI R25 DA022461 - Gourevitch (PI) - 06/01/2012 – 05/31/2017 NIH/NIDA Substance Abuse Research Education and Training (SARET) Role: Co-Investigator
Associate Professor, Department of Population Health at NYU Grossman School of Medicine
Associate Professor, Department of Medicine at NYU Grossman School of Medicine
MD from Albert Einstein College of Medicine
Fellowship, NYU School of Medicine, Department of Medicine, Division of General Internal Medicine
Residency, Brigham and Women's Hospital, Internal Medicine-Primary Care
Journal of substance abuse treatment. 2020 Mar; 112S:4-11
Drug & alcohol dependence. 2020 Feb 22; 209:107939
Addiction science & clinical practice. 2020 Jan 16; 15(1):4
Journal of addiction medicine : JAM. 2020 Jan/Feb; 14(1):32-38
Journal of general internal medicine. 2019 Dec; 34(12):2824-2832
Addiction science & clinical practice. 2019 Oct 15; 14(1):39
Contemporary clinical trials. 2019 Aug 22; 84:105833